Pharmaceuticals, Biotechnology and Life Sciences
ARLINGTON, Va.–(BUSINESS WIRE)–Battelle’s Principal Research Scientist-Biologist Vivian Smith has been named the 2019 recipient of the Dr. Billy Richardson Young…
Grant will support development of a new treatment for retinitis pigmentosa CLEVELAND–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BioMotiv?src=hash" target="_blank"gt;#BioMotivlt;/agt;–OptiKira, LLC, a privately-held biotechnology company…
TOKYO–(BUSINESS WIRE)–Modulus Discovery, Inc. (CEO: S. Roy Kimura, Ph.D., “Modulus”), an early stage global biopharmaceutical company, announced today the signing…
ATLANTA–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/OpioidCrisis?src=hash" target="_blank"gt;#OpioidCrisislt;/agt;–Pharmaceutical industry innovator Galt Pharmaceuticals aims to give physicians and patients an opioid-free alternative for the management…
VANCOUVER, British Columbia–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/endoscopy?src=hash" target="_blank"gt;#endoscopylt;/agt;–According to the latest suite of reports by iData Research, the United States gastrointestinal (GI)…
Accelerated pathway for companion diagnostic development granted to cell-free DNA assay for detecting HRD mutations and gene deletions KIRKLAND, Wash.–(BUSINESS…
DURHAM, N.C.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/ChipTray?src=hash" target="_blank"gt;#ChipTraylt;/agt;–Xona Microfluidics, LLC, (“Xona”), a life sciences company, is celebrating over 100,000 microfluidic devices and chips…
Enhances Evidera’s ability to leverage data to provide real-world evidence and insights for clients WILMINGTON, N.C.–(BUSINESS WIRE)–Evidera, a business unit…
SEATTLE–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BiochemicalReagents?src=hash" target="_blank"gt;#BiochemicalReagentslt;/agt;–According to Coherent Market Insights, the global Lifescience Reagent Market was valued at US$ 33,754.0 million in…
NEW YORK–(BUSINESS WIRE)–Oligomerix, Inc., a privately held company pioneering the development of tau oligomer inhibitors for Alzheimer’s disease (AD) and…